About wpadmin

This author has not yet filled in any details.
So far wpadmin has created 33 blog entries.

Umeåföretag tar nästa steg mot ett nytt läkemedel

PRESSMEDDELANDE 2019-03-06 Ladda ned pressrelase: Investerare satsar 25 MSEK på nytt läkemedel (pdf) » Umeåföretaget Lipum utvecklar ett biologiskt läkemedel för behandling av kroniska inflammationer. Tidigare pre-kliniska studier har visat mycket goda resultat och potential att ge en bättre behandling av till exempel ledgångsreumatism. ”Konkurrensen i branschen är hård så när vi nyligen fick 23 [...]

2019-03-06T15:02:49+00:00

Lipum to NASDAQ

On 6-7 March, Lipum attends a pitching event for Deep Tech companies in Stockholm hosted by The European Innovation Council (EIC) pilot and Nasdaq. The event is exclusively organised for EIC pilot- funded companies with the opportunity to pitch their business to top European investors and connect with Nasdaq representatives and partners. The 15 attending [...]

2019-03-04T11:02:54+00:00

New share issue round about to close on Sunday 17 February

Tomorrow, Lipum will close a share issue raising SEK 25 million in addition to support from Horizon 2020 of SEK 23 million grant. The capital will finance the preclinical work and the development of a production method up to the start of toxicology studies next year. See the full interview (in swedish) from BioStock [...]

2019-02-16T13:09:46+00:00

Lipum at Biostock Live – among listed companies

At this event we will present the progress of our unique and EU Horizon 2020 supported approach for treatment of chronic inflammatory diseases. In addition, it will also be an opportunity to learn more about Orexo with a market cap of SEK 2.6 billion. Surprisingly, the brilliant Swedish pop group Torsson will be represented. In [...]

2019-02-13T07:23:43+00:00

Exclusive partnering with nordic life science startups

Thursday 7th February we will spend with potential investors and partners together with 14 participating companies from Umeå. It's the annual Biotech Umeå Investment Day 2019. We are looking forward to this event since we are at the stage of finding investors for our exciting progress towards a new drug against chronic inflammatory diseases. We [...]

2019-02-05T12:51:08+00:00

There are plenty of opportunities in crowded immunology markets

  According to Johnson & Johnson there are still tons of opportunity in the immunology market, even though it´s crowded. Jennifer Taubert, executive vice president and worldwide pharma chairman recently said at the J.P. Morgan Healthcare Conference: “We do look at immunology as being very, very attractive, and in certain areas, there’s so much unmet medical [...]

2019-02-02T12:21:28+00:00

Lipum makes a share issue for faster progress

Being a European Commission Horizon 2020 beneficiary has a distinct positive impact on our development. The 2.2 M€ grant enables us to proceed faster towards a new drug against chronic inflammatory diseases. To further increase the momentum we are now raising additional funding by a share issue. Interested investors get a chance to join the [...]

2019-01-25T13:47:55+00:00

Lipum – towards production of its lead candidate

A range of CMO partners have been evaluated for cell line development and production of Lipum’s antibody. Next weeks our CEO and CMC Project Manager will travel to both Europe and the US visiting contract manufacturers before selecting this critical collaboration partner. To be continued ...

2019-01-25T13:48:04+00:00

“Investors are interested” – interview with CEO Einar Pontén

An article from Biostock In the northern of Sweden, Umeå, the privately owned company Lipum wants to draw the game plan for the treatment of chronic inflammatory diseases. The main assets are a new drug candidate and promising preclinical result for a unique target molecule. BioStock has met CEO Einar Pontén and discussed the past year [...]

2019-01-25T13:48:11+00:00